CTX (C-Telopeptide)
Clinical Biochemistry
Sample and container requirements
EDTA Plasma
Minimum volume required
0.5 mL plasma
Special requirements
Separate and freeze plasma within 24 hours of specimen collection.
Patient preparation
Suggest take samples for monitoring at approximately the same time of day to improve interpretation of results. Fasting is not required for this test.
Sample viability
Turnaround time
7 days
Reference range
Pre – menopausal females: 0.12 – 0.75 μg/L Post – menopausal females 0.19 – 1.00 μg/L Males >21 years: 0.15 – 0.77 μg/L Paediatric females: <6 years: 0.18 – 1.69 μg/L 7 – 11 years: 0.30 to 1.98 μg/L 12 – 16 years: 0.15 – 1.91 μg/L 17 – 21 years: 0.11 to 1.13 μg/L Paediatric males: <6 years: 0.45 – 1.76 μg/L 7 – 11 years: 0.66 – 1.98 μg/L 12 – 16 years: 0.39 – 2.13 μg/L 17 – 21 years: 0.23 – 1.55 μg/L (Source: Immuno Diagnostic Systems)
Clinical guidance
Please refer to LabTestsOnlineUK to learn more about CTX. https://labtestsonline.org.uk/tests/bone-markers
Notes
Images to go here
This information was last updated on 19 August 2026